PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
Spremljeno u:
POTTER, J.S., ET AL., PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK. JOURNAL OF SUBSTANCE ABUSE TREATMENT, Vol. 38, no. 4 SUPL. 1 (2010), p. S80-S86.
Ref.
169096
Lokacija:
SIIS R.991 Archivo
Palabras clave:
Buprenorfina, Dolor, Drogas ilegales, Drogodependencias, Efectos, Efectos, Factor de riesgo, Opiáceos, Recaída, Tratamiento médico
Buprenorfina, Dolor, Drogas ilegales, Drogodependencias, Efectos, Efectos, Factor de riesgo, Opiáceos, Recaída, Tratamiento médico
Slični predmeti: PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
- Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
- Predictors of dropout from inpatient opioid detoxification with buprenorphine. A chart review
- OPIOID DETOXIFICATION WITH BUPRENORPHINE, CLONIDINE, OR METHADONE IN HOSPITALIZED HEROIN-DEPENDENT PATIENTS WITH HIV INFECTION
- PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY
- EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS
- NALTREXONE SHORTENED OPIOID DETOXIFICATION WITH BUPRENORPHINE